Patient Profile: Eva Grayzel
When stage IV squamous cell carcinoma survivor Eva Grayzel shares her story, you can tell that she has a zeal for life. She survived oral cancer and works as a […]
Entries by GIna Craig
Eight Factors That Impact Advanced Prostate Cancer Treatment Decisions
Several key factors come into play for advanced prostate cancer treatment decisions. In the “Which Factors Impact Advanced Prostate Cancer Treatment Decisions?” program, expert Dr. Atish Choudhury from Dana-Farber Cancer […]
Three Promising Areas of Lung Cancer Research
What are three promising areas of lung cancer research? In the “Emerging Therapies| Hope for the Future of Lung Cancer Care” program, expert Dr. Jyoti Patel from Robert H. Lurie […]
Three Ways Patients Can Access Clinical Trials
What are some ways that cancer patients can access clinical trials? In the “How Can Clinical Trials Be Accessed?” program, expert Dr. Seth Pollack from Robert H. Lurie Comprehensive Cancer […]
Tribute to Outgoing PEN Board Member Jack Aiello
We at the Patient Empowerment Network (PEN) have been honored to have Jack Aiello as a member of our Board of Directors. Jack has served as a PEN board member […]
Four Factors That Impact a DLBCL Treatment Decisions
Diffuse large B-cell lymphoma (DLBCL) treatment options may map differently depending on various patient factors. In the “Which Factors Impact DLBCL Treatment Decisions?” program, expert Dr. Justin Kline from University […]
Three Main Treatment Approaches for CLL Patients
What are the main treatment approaches for Chronic Lymphocytic Leukemia (CLL) patients? In the “CLL Treatment Approaches: What Are the Types?” program, expert Dr. Catherine Coombs from The UNC Lineberger […]
Three Reasons MPN Patients and Their Families Should Continue Telemedicine
What are some reasons why MPN patients and families should continue to use telemedicine visits? In the “Should MPN Patients and Their Families Continue Telemedicine?” program, expert Dr. Kristen Pettit […]
Five Tips to Participate in MPN Care and Treatment Decisions
How can myeloproliferative neoplasm (MPN) patients become more active in their care? In the “How Should You Participate in MPN Care and Treatment Decisions?” program, expert Dr. Abdulraheem Yacoub of the […]
Value Assessments From Patient and Provider Perspectives
The cost of some cancer drugs and lack of healthcare access are shocking to some patients. Fortunately, a tool called value assessments are now being utilized to gather and analyze […]
Five Ways the PEN Empowerment Lead Program Can Support Your Cancer Journey
Our Empowerment Lead program is here to support patients and families around important topics and to provide navigation for the path to empowerment. Our Empowerment Leads are highly passionate empowerment […]
Four Factors in Advanced Non-Melanoma Skin Cancer Treatment Decisions
How can non-melanoma skin cancer treatment be determined? In the “Advanced Non-Melanoma Skin Cancer Treatment Decisions: What’s Right for You?” program, expert Dr. Vernon Sondak from Moffitt Cancer Center shares […]
Three Myths Busted About Non-Small Cell Lung Cancer
What’s the truth about non-small lung cancer myths? In the “Fact or Fiction? Busting Myths About Non-Small Cell Lung Cancer” program, expert Dr. David Carbone from The Ohio State University Comprehensive […]
Three Ways to Partner in Your Waldenström Macroglobulinemia Care
How can Waldenström macroglobulinemia (WM) patients become partners in their care? In the “Waldenström Macroglobulinemia Treatment Decisions: What’s Right for You?” program, expert Dr. Jorge Castillo from Dana-Farber Cancer Institute shares […]
MPN Patient Profile: Robyn Rourick Part 1
Though Robyn Rourick is a scientist by training and works for a biotechnology company, she took a mind-body approach to her myeloproliferative neoplasm (MPN) journey. The time that passed between […]
